Press-release for stocks publishing date 2022 - 05

Prices are updated after-hours

publishing date : 2022 - 05 - 04 source : Www.biospace.com

save search

Awakn’s Anthony Tennyson on Providing Hope for Those Suffering from Addiction
Published: 2022-05-04 (Crawled : 00:00) - biospace.com/
AON | News | $308.83 -0.97% -0.21% 850K

Finance

| 9.6% | O: -0.01% H: 0.0% C: 0.0%

Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results
Published: 2022-05-04 (Crawled : 21:00) - biospace.com/
ACAD | News | $16.57 -1.02% -1.03% 1.3M

Health Technology

| -15.5% | O: 0.71% H: 0.0% C: -0.3%
results

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results
Published: 2022-05-04 (Crawled : 21:00) - biospace.com/
DMAC | $2.5 3.31% 3.2% 7.4K

Health Technology

| -7.63% | O: 2.29% H: 1.12% C: -7.46%
therapeutics results

Athira Investor Calls For Former GSK Exec to Take Reigns
Published: 2022-05-04 (Crawled : 19:00) - biospace.com/
PPRUF | News | $340.0 37.56% 1.5K

Consumer Non-Durables

| -33.8% | O: 1.29% H: 0.33% C: -2.46%
PPRUY | News | $33.79 -0.11% 360K

Manufacturing

| -34.15% | O: 0.0% H: 2.48% C: 2.48%

Conformis Reports First Quarter 2022 Financial Results
Published: 2022-05-04 (Crawled : 18:00) - biospace.com/
CFMS | $2.26 0.44% 0

Health Technology

| 336.45% | O: 5.15% H: 0.57% C: -4.48%
results

Achilles Therapeutics Appoints Bernhard Ehmer to Board of Directors
Published: 2022-05-04 (Crawled : 17:00) - biospace.com/
ACHL | $0.7764 -0.6% -0.61% 120K

Manufacturing

| -66.52% | O: 2.15% H: 1.89% C: -1.68%
therapeutics

Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
Published: 2022-05-04 (Crawled : 17:00) - biospace.com/
OTIC | $0.077

Health Technology

| -96.92% | O: -0.8% H: 0.0% C: -1.2%
AGTC | News | $0.3936 1.23% 0.0%

Health Technology

| -58.72% | O: 0.48% H: 1.8% C: -4.96%
agtc-501 ongoing research positive phase 1

Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
Published: 2022-05-04 (Crawled : 16:00) - biospace.com/
ADAP | $1.085 -4.83% -5.07% 780K

Health Technology

| -37.36% | O: 1.65% H: 3.78% C: 3.24%

Sagimet Biosciences to Present Additional Biomarker Phase 2 Data on Denifanstat (TVB-2640) in NASH Patients at DDW 2022
Published: 2022-05-04 (Crawled : 16:00) - biospace.com/
SGMT | News | $4.15 -3.04% -3.13% 220K

Health Technology

| Email alert Add to watchlist
tvb-2640 nash biomarkers phase 2

Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-Injector
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
STVN | $27.31 0.33% 0.0% 190K

| 72.83% | O: 0.19% H: 3.61% C: 2.15%
aidaptus collaboration group

Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
ANVS | $12.74 7.24% -2.04% 490K

Health Technology

| 16.02% | O: 2.34% H: 12.21% C: 11.45%
results

Regeneron Overcomes Loss of COVID Antibody to Post Positive First Quarter
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -11.9% | O: -3.68% H: 0.0% C: 0.0%
covid antibody positive

Marker Therapeutics to Present Four Posters on its T Cell-Based Immunotherapies at the 2022 International Society for Cell & Gene Therapy Annual Meeting
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
MRKR | $4.425 5.42% 10K

Consumer Services

| 1162.86% | O: 1.0% H: 8.8% C: 6.93%
therapeutics therapy international

Minerva Neurosciences Reports First Quarter 2022 Financial Results and Business UpdatesCompany Expects to Submit an NDA for Roluperidone, Subject to FDA Guidance, in the Third Quarter of 2022
Published: 2022-05-04 (Crawled : 14:00) - biospace.com/
NERV | $2.53 0.0% 3.9K

Health Technology

| 404.99% | O: 0.0% H: 3.79% C: -0.2%
fda

Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma
Published: 2022-05-04 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -46.6% | O: -0.81% H: 2.0% C: 1.57%
treatment pharma antibody trial therapy nivolumab

Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
VCYT | News | $19.92 0.45% 0.45% 510K

Health Technology

| -7.6% | O: 2.19% H: 3.08% C: 2.37%
NSTG M | $0.1053 -37.43% -0.19% 0

Health Technology

| -99.44% | O: 0.21% H: 4.59% C: 3.64%
cancer breast cancer

RAPT Therapeutics Expands Leadership Team with Multiple Key Hires
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
RAPT | $7.905 -1.19% -1.2% 290K

Health Technology

| -47.44% | O: -1.12% H: 0.2% C: -0.6%
FGEN | $0.9844 -8.0% -8.7% 2.2M

Health Technology

| -88.99% | O: 0.31% H: 0.21% C: -0.62%
therapeutics

Tivic Health to Report First Quarter 2022 Earnings on May 16th Via Conference Call and Webcast
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
TIVC | $1.15 1.83% 1.8% 27K

| -29.38% | O: -2.5% H: 12.18% C: 8.97%
conference report health

Hologic to Webcast Presentation at Upcoming Investor Conference
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
HOLX | $76.71 -0.62% -0.63% 910K

Health Technology